- This event has passed.
Hemp CBD Q&A with Harris Bricken
September 17, 2020 @ 3:00 pm - 4:00 pm
Unless you’ve been living under a rock for the last few years, you’ve probably heard about cannabidiol, more commonly referred to as CBD. CBD is a cannabinoid that occurs in the cannabis plant. CBD is not intoxicating, unlike THC, but many consumers and businesses are intoxicated by the promise of CBD, which has led to the proliferation of CBD gummies, tinctures, lattes, vape cartridges, and even sports bras. There is an undeniable market for CBD products but manufacturing and selling these products is no cakewalk. We want to help you figure out what is really going on with CBD in the US and abroad.
Since 2016, our team of regulatory attorneys has been assisting domestic and international companies navigate the complex and ever-changing legal landscape of hemp-derived cannabidiol (Hemp CBD) products. As such, we understand how challenging and confusing engaging in this industry can be.
Our team will lead a FREE Q & A webinar on Thursday, September 17, 2020 from 12pm to 1pm PDT, during which our transactional hemp attorneys will field questions on all aspects of hemp and CBD, including guidelines by the Food and Drug Administration and the patchwork of state laws and regulation.
The panel will consist of attorneys Nathalie Bougenies (Portland) and Daniel Shortt (Seattle) and will be moderated by Griffen Thorne (Los Angeles).
This Q & A webinar is free to attend and we encourage all attendees to submit questions in advance while registering. The attorneys will answer as many as possible during the lunch hour.